Fibrocell Science, Inc., (NYSE MKT:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today announced that David Pernock, chairman and chief executive officer, and Greg Weaver, senior vice president and chief financial officer, of Fibrocell Science will present at the Jefferies 2014 Global Healthcare Conference at 3 p.m. EDT on Thursday, June 5, 2014, in New York City.
Help employers find you! Check out all the jobs and post your resume.
